Imbed Biosciences Inc
Microfilm wound dressings with silver nanoparticles that seal wounds to balance moisture and kill bacteria at the onset of wound treatment.
Imbed is developing patent-pending antimicrobial nanocoatings for advanced wound care and surgical devices. It is a spin-off from the University of Wisconsin-Madison. After 2 years of development, we have our first packaged product- Microlyte Ag wound dressing intended for use at the onset of treatment of hard to heal wounds including burns and chronic ulcers. FDA 510K submission anticipated within 6-9 months with product sales in 12-15 months.